Phase Ib-IIA study of combined check point inhibition after autologous hematopoietic stem cell transplantation in patients at high risk for post-transplant recurrence

Sponsor
Hackensack UMC

Protocol Number
Hackensack UMC CPIT Trial 001 (CA209-694)

To Learn More Call
201-510-0910